Budget Amount *help |
¥17,290,000 (Direct Cost: ¥13,300,000、Indirect Cost: ¥3,990,000)
Fiscal Year 2021: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Fiscal Year 2020: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2019: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2018: ¥5,330,000 (Direct Cost: ¥4,100,000、Indirect Cost: ¥1,230,000)
|
Outline of Final Research Achievements |
A mouse model of human septic peritonitis was created and the function of innate immune cells in the lungs and abdominal cavity was observed. In the model of moderate severity (about 10% mortality), the function of alveolar macrophages in the lungs was found to be suppressed, with reduced maturation marker expression, even on day 4, where mice were in the recovery period. Impaired function and maturity were restored by systemic IFNβ administration or transtracheal GM-CSF administration. In the severe sepsis model, abdominal phagocyte function was greatly reduced as well and was restored by systemic IFNβ administration. However, this effect was not seen when prophylactic administration was given before sepsis.
|